Answers are grounded in this paper and cite their sources.
The UK Industrial Biotechnology (IB) Strategy presents a consistent plan to develop the IB sector but fails to endorse an innovation process that allows for input from multiple publics. This could be disadvantageous for the bioeconomy: there are notable cases where negligence to address societal dimensions has caused innovation failure.
No takes yet. Share an insight, caveat, or question.
Rosemann et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: